Upcoming Events
Log In
Pricing
Free Trial

Mastering Cardiac CT: Essential Fundamentals and Emerging Clinical Frontiers, Dr. Prashant Nagpal (9-10-26)

HIDE
PrevNext

0:02

Hello, and welcome to Noon Conference hosted by Modality.

0:05

Noon Conference connects the global radiology community through free, live

0:09

educational webinars that are accessible for all and is an opportunity to learn

0:12

alongside top radiologists from around the world.

0:16

Today, we're honored to welcome Dr.

0:17

Prashant Nagpal for a lecture entitled "Mastering Cardiac CT: Essential

0:22

Fundamentals and Emerging Clinical Frontiers." Dr.

0:25

Nagpal completed his radiology residency at the University of Iowa and his

0:30

cardiovascular imaging fellowship at Brigham and Women's Hospital, Harvard Medical

0:33

School. He currently leads the section of cardiovascular imaging at the University

0:37

of Wisconsin-Madison, specializing in advanced cardiac and vascular imaging.

0:43

At the end of the lecture, please join him in a Q&A session where he will address

0:46

questions you may have on today's topic.

0:49

Please remember to use that Q&A feature to submit your questions so we can get to

0:52

as many as we can before our time is up.

0:55

With that, we are ready to begin today's lecture. Dr.

0:57

Nagpal, please take it from here.

1:00

Thank you. Thank you so much. First of all, welcome, everybody.

1:03

Thank you for attending this noon lecture about cardiac CT. Okay.

1:08

My goal is to touch upon two spectrums of cardiac CTs, knowing that the learners

1:15

are from different backgrounds, they all have different areas of interest.

1:19

So I'm going to teach a little bit about the basics of cardiac CTs and talk about

1:24

how we acquire and what are the basics that we must keep in mind, and also touch

1:28

upon where the field is going. Obviously, it's growing so vast and in so many

1:34

areas, I cannot do that all in one lecture, but I'm just going to give a brief

1:39

trailer of what's coming. With that, let's dive in.

1:45

First of all, here are my disclosures.

1:48

And along with that, I certainly also

1:54

work with Modality for these educational initiatives.

2:00

So the objectives of this lecture today is, one, to understand how cardiac CT

2:06

is acquired and understand basic protocol and acquisition techniques.

2:12

This is one of the basics, especially for early learners, those who are just

2:17

starting to learn how cardiac CT is done.

2:22

We'll briefly talk about some emerging role of advanced applications for coronary

2:27

CT, as well as discuss a little bit of data on why coronary CT is such an important

2:33

test. Beyond that, we will discuss some case examples to show the role of cardiac

2:39

CT for coronary evaluation, as well as some non-coronary cardiac evaluation.

2:45

With that, first, let's dive in in the basics and imaging principles.

2:51

So the way I think of cardiac CT is the journey of a cardiac CT, and

2:57

again, I call it a journey because there are multiple steps involved.

3:01

So journey obviously initially starts from an order.

3:06

I'm not going to talk about the order part, but as an imager, it

3:11

starts at the time of patient preparation and then involves image acquisition.

3:17

Then once the images are acquired, it goes on to image display, understanding

3:23

artifacts, as well as understanding common and challenging scenario that we

3:28

encounter in our day-to-day practice.

3:31

The common ones are high heart rate, arrhythmias, obesity, stents, and other

3:37

metal things in the heart, like pacemaker and ICDs.

3:42

I'll try to touch upon most of these.

3:45

Obviously, this is a one-hour lecture, I cannot do that all in this one hour, but

3:51

I'll try my best to touch upon things.

3:55

So, as I said, our journey starts when the patient arrives.

3:59

So in terms of how do we take care of the patient, the basic instructions that we

4:04

provide to patients are they're supposed to hydrate normally.

4:08

We ask them to have water up to the time of scan, and obviously encourage water

4:13

after. After this,

4:16

we also encourage normal diet. We don't ask people to have overnight fast or

4:21

anything for scan itself. One preference is to have no food for three to four

4:26

hours. But more important than just food, we really focus on things that can

4:32

affect patient preparation in terms of no caffeine for 20 to 24 hours,

4:38

including decaffeinated drinks.

4:40

This is because we want to have slow, steady heart rates.

4:43

Similar logic applies to exercising.

4:48

We basically are aiming for a slow, steady heart rate.

4:51

We encourage people and ask people to continue their usual cardiac medications like

4:56

beta blockers, but certain medications like phosphodiesterase inhibitors, like

5:01

sildenafil or tadalafil, should be discontinued 48 hours prior.

5:08

Obviously, there are other checks that happen before even the patient comes.

5:13

We make sure we look for prior contrast reactions, the type and severity.

5:19

We ensure patient's renal function is okay, and obviously look for pregnancy status

5:24

as well as any metal in or near the heart which can affect the

5:30

reconstruction protocol. Then beyond that,

5:34

this is again, a local protocol. We use a single source scanner.

5:39

So single source, and I'll come to that why this difference is important.

5:43

Single source means that there is one X-ray source.

5:46

And for those scanners, heart rate control is really critical.

5:51

So since we are a single source site, we aim for less than 60 beats per minute

5:56

heart rate, and we primarily rely on metoprolol for these.

6:01

So we use, depending on the heart rate, metoprolol oral one hour before the scan.

6:07

We sometimes use IV top-ups as needed.

6:10

We also use ivabradine or diltiazem as indicated.

6:16

And of course, knowing these contraindications for these medications, like

6:22

beta blockers with high rate AV block, severe reactive airway, which is probably a

6:27

relative contraindication and

6:30

low blood pressure. And same, we always use sublingual

6:35

nitroglycerin when we can. When I say always, it is obviously making sure that

6:41

patient does not have a contraindication to use of

6:45

these medications which are listed here.

6:48

Our goal is to use at least two tablets, that is 0.4

6:54

milligram, two tablets, that is 0.8, but obviously we give it only when it is

6:59

stable, especially when the systolic blood pressure is more than 110.

7:04

At less than 100 we hold, and between 100 and 110 we give 0.4 milligram.

7:09

Important thing about nitroglycerin that we give sublingual, you do not scan

7:15

right away. You have to wait three to five minutes.

7:18

So what we do is that we basically have the patient on the table, give

7:22

nitroglycerin, and then start planning the protocol and calcium score and then

7:27

contrast administration. That gives us three to five minutes timeframe without

7:31

doing it outside the CT entry. Now, obviously, you have now

7:38

kind of prepared the patient for the scan. You have explained the scan.

7:42

Then comes the part of you are going to inject contrast.

7:48

Now, when we inject contrast, understanding the injection

7:53

protocols is important.

7:56

Injection protocols are either monophasic, in which as you see, all we do is that

8:02

we give contrast. No saline after that. We just inject contrast and we scan.

8:07

This is, I would say, the least commonly or almost non-existing

8:13

contrast protocol. I do not think we use it in any patient.

8:18

The common protocols that we use, biphasic protocol is actually for coronary

8:23

imaging, the most common protocol that we use.

8:26

We basically give contrast followed by saline, and this is kind of our workhorse

8:33

for imaging. Then, there is a triphasic protocol that we also use

8:39

very commonly in cardiac imaging, not for coronary, but for other cardiac imaging,

8:46

in which we give contrast, and then we give a contrast saline mix followed by pure

8:50

saline. This is basically whenever you want to have right and left heart together.

8:56

So for us, there are certain indications.

8:59

So for example, if- You want to have

9:04

intracardiac thrombus evaluation, in which you want to see thrombi in any side of

9:09

the heart. We also use this extensively in our congenital heart disease

9:15

patients because you want to have both pulmonary artery and aorta

9:21

evaluated along with coronaries in this population.

9:25

There is another alternative to having both right and left heart is, very

9:30

certain injectors are capable of doing multiple small splits.

9:35

It's not very common, and it's only injection specific.

9:39

Interestingly, in our practice, we have that injector and we have very good results

9:44

with that. But for you to think of is, this is how

9:50

I understand that for coronary imaging, you will be using biphasic for most part.

9:56

And if you need both left and right heart, you will be using triphasic protocol.

10:01

I think that should kind of simplify the understanding, and monophasic is rarely

10:07

ever the correct answer. In my experience, we almost never use it.

10:13

Saline flush is very important, and

10:17

it pushes the contrast from the veins into the central circulation, and it also

10:21

clears the contrast out of the SVC and right atrium.

10:25

And for coronary imaging, it is very, very important because otherwise you cannot

10:29

see your right coronary artery very well if you have dense contrast in the right

10:33

atrium.

10:35

And I'll show you an example of that, too.

10:37

So this is kind of how our injectors look for those who do not have much experience

10:43

with coronary imaging yet, or any cardiac imaging yet.

10:47

And basically, there are two heads, one in one we fill saline and in one we fill

10:52

contrast. And the screen

10:56

frequently looks like this. If you see, this is an example, if somebody asks you

11:01

what kind of contrast bolus is this? This is a triphasic contrast bolus.

11:05

You have given first contrast, so green is basically contrast, contrast, then

11:10

contrast saline mix, and then only saline.

11:13

So this is a typical example of a triphasic contrast.

11:17

Now, this image shows how a monophasic contrast looks like.

11:23

There is very dense contrast coming in the SVC right atrium.

11:27

And as you can imagine, if you were doing this for coronary imaging, even though

11:31

the left heart assessment may be okay, the right coronary artery is completely

11:36

obscured by artifacts, which we don't want.

11:40

So for that, this is the kind of image we really like to have for coronary imaging.

11:45

That's why I said,

11:47

before coronary imaging, what we want is a biphasic protocol.

11:50

That means we gave contrast, and that contrast is in the left heart, and then we

11:54

gave saline, which kind of washed everything out of the right heart.

11:58

There is still a little bit left, but again, doesn't matter.

12:02

In this area, even if it is there, it is not dense enough to cause streaks, and it

12:08

gives you a very good imaging for the right heart.

12:12

And this contrast setting is also very good to look for very subtle shunts like

12:17

PFO, in which you can see contrast jet going from left to right, sometimes

12:22

you'll see that. So this is our most preferred and most widely used contrast

12:28

bolus. This is the triphasic contrast bolus.

12:32

As I said, we sometimes use it depending on the indication of the study.

12:36

The most common study in which we use is basically congenital imaging.

12:41

So just to give you a perspective, this is a biphasic contrast.

12:46

This is how the images, when you scroll through, look like.

12:48

Beautiful contrast in the left heart and almost nothing in the right heart because

12:53

we gave saline. And the biphasic doesn't mean you cannot do right heart

12:59

imaging with this. This is also a biphasic contrast, but timed for right heart

13:04

evaluation. So you can use biphasic contrast in either ventricle.

13:10

Just the way it helps in the right heart is it kind of gives

13:16

great timing. And this is our triphasic contrast, in which we gave it and now you

13:21

have enhancement of both sides, so you can evaluate diseases on either side.

13:27

So this is about contrast

13:31

administration. Now, let's say you have decided how you are going to inject.

13:37

How do you scan or how do you figure out when to start

13:42

acquiring images once you have given the contrast?

13:46

So the way we do it is called as a scan delay.

13:49

So

13:50

for those who do imaging of other organ systems, like for example, chest imaging or

13:56

abdominal imaging, you probably know that we have a fixed delay

14:02

time. Like for example, for abdominal pelvis routine exams, we wait 60 seconds.

14:08

Or for chest imaging, we wait 60 seconds and then we acquire.

14:11

In cardiovascular imaging, you cannot do that because you

14:18

want to time your acquisition when there is peak enhancement.

14:22

And peak enhancement depends on patient's physiology.

14:26

So what we do is that we basically monitor where the

14:32

contrast is, and based on that monitoring, we look when it is peaking in the

14:37

ascending aorta. Then there is a slight post-threshold delay because we want

14:44

two to four seconds to allow complete filling of the coronary arteries.

14:47

So what we are doing is we are looking at the aorta, looking at the peak of that

14:52

aorta, aortic contrast, and as soon as there is a peak, we basically give breath

14:58

holding instructions like, "Hold your breath." That takes care of that two to four

15:02

seconds for coronaries to fill in, and that is basically how we do it.

15:08

Even in that, there are two methods.

15:10

One is called as a bolus tracking, in which what we do is that we basically take

15:16

an image, and then on that image, we put a ROI.

15:22

And as soon as it crosses a certain threshold, like in this case, it was 100

15:28

Hounsfield unit in the aorta. And as soon as it crossed 100 Hounsfield units in

15:34

the aorta, the scan got triggered.

15:36

So

15:39

basically, this is how it looks. This is an example of bolus tracking.

15:45

And what we do is that depending on what type of enhancement we want, if you want a

15:49

left heart enhancement, you can trigger off either the descending thoracic aorta or

15:54

the ascending aorta. As soon as the contrast crosses, let's say, 100 Hounsfield

15:59

units, there is a slight post-scan delay to give reading instructions, the scan

16:05

would start.

16:08

There is no particular preference in our program.

16:11

We don't like using ascending aorta, even though it is bigger.

16:15

The reason is sometimes the contrast, when it is coming from the SEC, it can cause

16:21

streaks, and those streaks can sometimes falsely trigger the scan

16:26

early. So we personally prefer doing it off the descending thoracic aorta.

16:31

But I've worked at programs that do

16:34

ascending aortic triggering, and somehow it works.

16:37

And again, there's nothing wrong here if your program does that.

16:42

As long as you are not having too many of these cases that are wrongly triggered,

16:46

then you should look into descending thoracic aorta.

16:50

Then obviously, if you want a right heart only scan, just trigger it off the main

16:55

pulmonary artery. We use it for a lot of our scans in which we are looking

17:01

at tricuspid assessment or tricuspid valve implant planning,

17:06

or what we call STVR planning. So we do use them.

17:11

The second type of triggering is called as test bolus.

17:15

This is not used very common. We use it sometimes in patients who have very

17:20

unusual physiology, like in patients with fontane circulation.

17:24

We want to really time it exactly when we do.

17:28

So in this, what we do is that we basically inject contrast, a small amount of

17:32

contrast, and then we see how contrast travels through the body.

17:38

And once we see how it travels through the body, we create these curves.

17:42

So first contrast comes in the pulmonary artery as we inject in the systemic vein,

17:47

and then it comes in the aorta. So we measure the exact time it takes.

17:52

So in this case, it's around 20 seconds it came in the aorta.

17:58

Then we would add a little bit like, for example, four more seconds or three more

18:02

seconds. They are called flush factor or whatever you can call it, time it takes

18:06

for coronaries to fill in. So, on time bolus you get 20,

18:12

you would basically scan at 22 or 23 seconds, and you will get excellent contrast

18:18

enhancement. Obviously, the problem with this is that to get this time bolus graph,

18:24

you have to inject 10 to 20 ml. And it works very well in

18:29

unusual physiology, but then it costs you extra contrast, extra time, and a

18:35

little dose. Also, at least for us, our techs are very comfortable doing bolus

18:41

tracking. It's more efficient. We do so many cases a day.

18:45

We basically practically almost never do test bolus except when we know that we

18:51

have a fontane patient with extreme collateral load coming in, then that's the only

18:56

time we use it. So, okay, so you have decided what type of contrast you are giving,

19:02

how you are going to trigger, what should be your field of view.

19:06

So for normally all coronary CTs, we only acquire the heart, and in that

19:12

acquisition,

19:15

basically we acquire the scout image or a topogram image, and this goes from

19:21

the level of the carina to the base of the heart.

19:23

That's the most common

19:26

Z-axis coverage that we go with. Now, obviously, not every cardiac CT is a simple

19:32

coronary CT. In patients with bypass grafts, we aim to go just above the lung

19:38

APCs because you want to make sure the entire lima to LAD is included.

19:44

You want to assess subclavian origins.

19:47

You want to assess lima patency from the top.

19:51

So that's why you must go higher, and the landmark that we read in literature is

19:57

either you go higher than the lung APCs or you just go to the midcarinal level.

20:01

It depends on how you want to remember.

20:04

So other indications in which we do broader coverage is patients with congenital

20:08

heart disease. As I said, frequently, the question is, we'll get a cardiac CT, but

20:12

the question is, can we make sure patient does not have coarctation or anything

20:17

else going in aorta? So we want to cover the entire heart.

20:20

Also, it's not

20:23

that uncommon to get cardiac CT plus aortic sizing or any other aortic

20:29

pathology together, and in those cases, we cover the whole chest.

20:35

In terms of how we acquire cardiac CT, so obviously,

20:41

heart is a moving organ,

20:43

and you don't want to acquire through motion.

20:47

So we basically

20:49

sync our acquisition with cardiac cycle.

20:53

And we can sync it through three ways.

20:56

Actually, mostly remember it as two ways.

21:01

One is prospective. That means we tell the scanner, "This is the part of the

21:05

cardiac cycle I want acquired." Retrospective is when you acquire throughout the

21:10

cardiac cycle and then later on bin your images in certain parts of cardiac cycle.

21:15

That's how I would think of. And the thing is that prospective or when you tell the

21:21

scanner, "This is exactly I want," that's low dose, but you don't get too much

21:26

data. It has little flexibility. You obviously cannot get cardiac

21:31

function out of it, whereas retrospective gives you a lot more flexibility.

21:37

So prospective ECG triggering is also called as step and shoot mode.

21:41

In this, if you see what happens is you acquire a first slab, then there's stable

21:46

motion. You acquire second slab, there's stable motion, then you acquire third.

21:50

And if you think of your entire acquisition, depending on scanner that you have,

21:56

each slab gets acquired in a certain time period.

22:00

Now, if you have what is called as a volume scanner, that means the scanner that

22:04

can acquire 16 centimeter in one heartbeat, you do not have this problem of

22:10

multiple slabs. But most scanners that are used, they have these small

22:16

slabs. So it's basically acquired across, in this case, four heartbeats.

22:21

So that means you can have what is called a step artifact.

22:25

If patient either has respiratory motion or irregular heart rate, you can

22:31

have some artifacts that come with it.

22:34

So along with that, so this is basically how we basically acquire

22:39

at 40%, and you start, even though this heart rate is so regular, it

22:45

basically was 85 to 78. It's fairly regular heart rate.

22:50

Even then, I can tell all these slabs that were acquired, and I can tell these were

22:55

each one heartbeat. So that's kind of one disadvantage of

23:01

prospectively triggered scan, but at the same time, they come with a lot of

23:05

advantages of lower radiation dose and actually giving you good diagnostic

23:10

information. So I would say other than valve imaging or like TAVR and others,

23:16

I think prospectively triggered scans have become the standard of care for

23:21

cardiac imaging.

23:24

Retrospective imaging, as you can imagine, we discussed, you are acquiring the data

23:29

the whole time. You basically acquire it whole time.

23:31

This is also called as helical. So you basically acquire, now you can acquire with

23:35

full radiation dose, or you can acquire in the desired portion with higher dose and

23:41

then reduce the dose. So that's how we do it.

23:44

And this is where we are changing the dose.

23:48

So in certain areas, you see excellent quality, and then in certain, the image

23:51

quality is relatively poor. This is called as dose modulation.

23:55

Whereas sometimes we acquire full retrospective.

23:58

This is a patient with TAVR who was having increasing gradients.

24:01

So we acquired like a full cardiac CT, and in this we had

24:08

basically no dose modulation. So this leads to very high radiation to patients.

24:13

Now, this one is a prospectively triggered but high-pitch helical.

24:19

This is

24:22

a unique scanner specific thing or vendor specific thing in which they have

24:28

dual-source scanners, and this mode is also frequently referred to as

24:34

flash mode. Basically, in this one, what happens is the scanner records the heart

24:39

rate, and in a very fast single sweep, it captures just this portion of the

24:45

cardiac cycle. The problem with this is that if

24:51

you record something about it and the heart rate changes, the scanner cannot

24:55

change, and you just get one shot at it.

24:59

So basically, we use it if the scanner is available.

25:02

This is primarily used in an ideal patient with low regular heart rate.

25:06

If there is any variability, this mode tends

25:11

not to work. Now,

25:14

we talked a little bit about single-source scanner, dual-source scanner.

25:18

I used these terms a few times. The reason this is important is basically

25:24

to get a cardiac image or to see one image on a cardiac scan or to

25:30

acquire that volume of the scan,

25:34

you need to have approximately half rotation around the patient.

25:39

So let's say this is the patient or the heart. You need to have half a rotation.

25:44

Now, in a single-source scanner, which is the most common scanners that we have,

25:49

you need to go through the entire half rotation.

25:52

So for example, if this gantry is rotating at

25:57

240 millisecond or 0.24 seconds, your temporal

26:02

resolution is around 120 because 120 is half of 240.

26:08

Now, if you have two sources or dual-source scanner, your each source can move just

26:14

quarter around or 90 degrees around, and that would each both 90 plus

26:20

90 would make it 180. So the same 250 millisecond rotation gives you

26:26

a temporal resolution of 60 milliseconds.

26:28

So you can actually resolve at much faster heart rates.

26:33

So the way you should think is, depending on what scanner is available in your

26:38

practice, you can meet different heart rate goals.

26:41

So if I have a single-source scanner, like I mentioned, we have a single-source

26:46

scanner. My heart rate goals are to make sure patient has a heart rate preferably

26:51

less than 60, definitely less than 75.

26:54

Now, on a dual-source scanner, are very forgiving.

26:57

You can go at much higher heart rate, and even up to 9,200 I've

27:03

seen reasonably diagnostic scans coming out of dual-source scanners.

27:07

So that's the advantage. Now, what phase of the cardiac cycle you trigger for?

27:13

At higher heart rates, systole is very, very consistent.

27:18

Basically, at slower heart rates end diastole or mid diastole is what we aim for

27:24

because it's the longest quiet phase of the cardiac cycle.

27:30

Now, as the heart rate increases, diastole is the phase that decreases, but

27:36

the systole remains consistent. So that's why at higher heart rates end systolic

27:41

acquisitions are more predictable, so that's what we aim for.

27:47

Same is true for arrhythmia patients, that when you have arrhythmia patients,

27:52

systole is what is more consistent.

27:55

So for example, if you have a patient whose heart rate, who's in AFib, and the

27:59

heart rate moves on the scanner at from 40 to 60 to 80 to 120, the

28:04

most consistent part in those is going to be systole.

28:09

Now, a little bit on why this information is important, because

28:15

you get

28:17

radiation dose based on what you choose. Okay? Radiation dose is an entire topic.

28:23

Just to introduce it here, basically, you get what was the

28:29

tube output, that is CTDI volume. This is the tube output.

28:34

This is dose length product. That means it accounts for the tube output multiplied

28:39

by the length you scan, the z-axis you scan.

28:42

So then if you take this dose length product and multiply it with the chest k

28:47

factor, then that's what you get effective dose.

28:51

So ACR says that the relative radiation level for

28:57

coronary CT is between one to 10 millisievert.

29:00

And for most part, if you see, almost all of the cardiac

29:06

CTs fall under that. The basic modes that we do is

29:11

basically prospective, and that is two to four millisievert.

29:15

If you see this, it says prospective with wide padding.

29:19

Padding just means that instead of acquiring an absolute 70% or

29:25

an absolute 45%, I have a slight buffer.

29:28

I just go from 25 to 45% or 60 to 80%. Padding is that buffer.

29:34

So it adds this, but it basically gives you some more leverage.

29:40

This is the least commonly performed scan, retrospective helical, basically the

29:45

entire cycle without any tube modulation.

29:49

So this is where you should be just a little bit careful when you do that.

29:55

Then you've acquired the scan. How do we visualize it?

29:59

Obviously, these images, more than anything, I just want you to remember the names.

30:04

This is how axial acquisition looks like.

30:07

Basically, this is virtual cross-section imaging through the

30:12

patient's chest. This is how axial images look like.

30:15

We can reconstruct these images in different planes.

30:18

So for example, this is the C view of the RCA.

30:21

These are called as curved planar reformats.

30:25

This basic example is a multiplanar reformat.

30:29

You take axial and you reconstruct an MPR. This is basically how we do it.

30:36

Then you can also see these images as these virtual

30:42

models, and this is called as a volume rendered image.

30:45

You basically have given volume to each structure, and these curvilinear images

30:50

that whenever you see, these are called as curved planar reformat.

30:54

So this is curved planar reformat.

30:57

You can reformat every vessel,

31:00

as a curved planar, it helps you to just visualize the entire vessel in one image.

31:05

But these are the names you should be aware of.

31:10

So one thing to remember that cardiac motion artifacts are usually phase specific.

31:15

That means that, for example, if you are reviewing the coronary CT and you saw an

31:21

image like this, and this is a 75% phase, so this is where at the origin of the LV

31:27

you see pretty tight stenosis.

31:31

Always make sure that if you have available, always look at different phases to see

31:36

if this is just motion. Because in the same patient, if you go and look at it in

31:39

systole, sorry, you go from just 75 to 80% phase, that

31:45

area just completely clears itself. So this is very important.

31:50

So cardiac motion is phase specific, so always

31:54

look for these. Irregular rhythms or high heart rate.

31:59

Obviously, it's implied lower heart rate is better.

32:02

If you have very high heart rate, it's one justification to do retrospective

32:07

gating.

32:08

But one important thing I want you to take home is faster heart rates you want to

32:14

acquire in systole. Obviously, go for the highest temporal resolution.

32:19

Whenever heart rate is high, avoid any other artifacts.

32:23

Make sure your contrast delivery is perfect, your signal-to-noise ratio is perfect,

32:27

patient is not bleeding. And

32:31

the likelihood of success based on all factors.

32:33

If there's a low pretest probability, low calcium score, and for broader graft

32:39

potency, usually it's okay, but patient who has very high heart rate, high BMI, and

32:44

you're looking at multiple small scans, it's going to be challenging to give out

32:49

their answer. So basically, understanding nuances

32:55

on how to do this is very, very important.

32:58

And also understanding any kind of arrhythmia management

33:04

that you can do by ECG editing is very important.

33:07

So for example, this is one case in which, if you see, this was a

33:12

patient, came in with high heart rate.

33:15

In diastole, this is how the images look like.

33:18

Really cannot do or diagnose and rather than report this as non-diagnostic,

33:24

just look in systole.

33:27

You can always, not always, you can most times find a phase in which you can

33:32

diagnose things. Same thing. This was a patient, we did it on one of-- so basically

33:38

it's an example from one of the older generation scanners.

33:42

And if you see, there is slab artifacts, and you can see how much of these slab

33:47

artifacts happen when patients have slightly irregular or any heart rate,

33:55

like varying RR interval. So this was a patient with arrhythmia, and this scan

33:59

practically looked non-diagnostic.

34:02

And if you look at the patient's

34:05

ECG trace in the scanner, and you can see there's a lot of, basically

34:10

the

34:14

patient recorded a lot of PVCs as

34:19

QRS complex. So all you have to do is delete some of these

34:25

abnormal heartbeats and just label the correct QRS and label the PVCs.

34:31

And as soon as you do some ECG editing, the same case went from being completely

34:37

non-diagnostic to having a fully diagnostic scan.

34:41

So, this is where I think, and this is called as ECG editing, and some of the

34:47

advanced applications function, obviously, for ECG editing is typically possible

34:53

in retrospectively gated scans only.

34:56

For prospective scans, one thing that we really focus on is arrhythmia

35:02

rejection. And in these patients, what happens is,

35:07

the scanner records the expected heart rate.

35:10

Now, if the expected heart rate is different by a certain

35:14

percentage, so for example, let's say 1,000 milliseconds is the expected

35:21

RR interval, or basically it's

35:24

60 beats per minute. Now you suddenly start acquiring and patient

35:29

had a PAC, and then the RR interval went to 700, it would

35:35

stop. It would not scan that heart rate, and it would move to the next heart rate.

35:39

And as soon as the heart rate is within 10% of what was the expected heart rate,

35:44

that means it went from, let's say, 950 to 1,050, it would acquire

35:50

the scan. So these are called as arrhythmia rejection algorithms.

35:54

These are very useful and should be turned on.

35:57

Another thing is atrial fibrillation, one of the most common scenario that you will

36:03

see. For these, we do prospectively gated scans with end

36:09

systolic reconstruction. So one very important tip for AFib patients is

36:15

that do not do percentage RR based reconstruction.

36:19

Just do a millisecond after R wave.

36:22

The reason for this is that, for example, if you were doing percentage-based

36:26

reconstruction, and this is the patient's-

36:30

Our basically ECG rhythm. 50% here is going to be, let's say all of

36:36

these initial ones are 60 beats per minute or 1,000 milliseconds.

36:40

So 50% is 500. This is approximately 500.

36:44

Now, this patient's heart rate varied, and now 50% is 800 because it became

36:50

1,600 milliseconds. Then it came back, then it became slower, and now the 50% is

36:56

300 milliseconds. That's the problem with percentage-based reconstruction.

37:00

Whereas if you use millisecond-based reconstruction, it basically moves.

37:05

It's 500 milliseconds after the previous R wave.

37:09

So every time it's going to be consistent, even if the RR interval keeps varying.

37:15

So this is one very important point.

37:18

You can really save a scan in a patient with AFib by using these millisecond-based

37:23

reconstruction. Same thing, moderately obese patients.

37:27

The problem with them is how much radiation that can go in.

37:31

What you can do is, obviously, you want the maximum photon

37:36

penetration, so at least use 120 kV.

37:42

And with that kV, maximize your tube mA.

37:46

These are the two things that you can do.

37:51

Also, whenever there is an obese patient, I always focus on how important it is

37:56

heart rate control. When you have an expectation of a slightly lower quality, you

38:02

cannot compromise on other things. Okay?

38:05

So other things is you can use a soft filter or a soft kernel.

38:10

Do not use, let's say, a lung kernel.

38:12

Otherwise, obviously, unless they do the stent, then you have to.

38:16

You can use higher degree of iterative reconstruction, like deep learning

38:20

reconstructions. So with this, in our experience, this is a, for example, a

38:25

patient whose BMI was close to 51, and we can get very

38:31

high-quality imaging, even with very high BMI.

38:37

You can also use, as I said, a higher degree of iterative

38:42

reconstruction. Not every iterative reconstruction I would suggest, but certain are

38:48

very good. This is one of the exercises we did last year, and we moved to higher

38:54

degree, higher strength of deep learning iterative reconstruction at our scanner.

39:00

And it's something that we published on is how it really does

39:06

not affect image texture or our ability to characterize stenosis, but just

39:12

decrease the noise. And noise is this graininess that you see on image, and see how

39:16

it is decreasing without changing our confidence in diagnosing this

39:22

area of tobacco stenosis. So in stents or high calcium, the

39:28

thing that we do is obviously you want to have good amount of radiation going in.

39:33

So, 100 to 120 kVp have good amount of mA going in,

39:39

and beyond that, you need slightly sharper kernels for reconstruction.

39:45

So these are the things

39:48

we focus on. And for stents,

39:51

our technical learning is that more than three-millimeter stents are okay.

39:58

Obviously, with photon counting, I think that's going to be redefined.

40:02

I have a feeling that we are able to see lumen of even smaller stents.

40:08

Okay. One very big tip is while interpreting these exams,

40:14

always widen the window and level, because that would decrease your blooming

40:20

through this. So that's very important when you are reading these scans.

40:24

This is just an example of our experience.

40:27

These were our conventional energy integrating detector scanner, and we basically,

40:33

the same patient got a scan on a photon counting scanner, and you can see how well

40:38

you can see the lumen. And you tend to underestimate calcium.

40:43

You basically characterize the stenosis much better on these photon

40:49

counting scans. Same has been our experience with smaller stents.

40:53

Like I said, this was a 2.5-millimeter stent in the left circumflex coronary

40:58

artery, and very easily we can diagnose things with this.

41:02

So,

41:04

I'll just slightly quickly go through a few things like this on applications of

41:10

how we are using cardiac CTs, not just beyond evaluating

41:16

stenosis and atherosclerosis. This was a 25-year-old patient who was having chest

41:20

pain evaluation, and these are the things in which cardiac CT is very good and very

41:26

important. This patient, if you see, has a coronary anomaly in which you see

41:32

a proximal part of the coronary artery.

41:35

The right coronary artery is coming from the left, and then it has a narrow

41:40

slit-like, or it's really seen very well in these volume rendered images.

41:45

So this is the basically left sinus of Valsalva, which gives out the left

41:51

coronary artery, and from the same is coming the right coronary artery with acute

41:55

angle as well as slit-like origin.

41:57

So basically what we have is an anomalous right coronary artery from the left cusp

42:03

with an inter-arterial course. Now, a few important things to highlight in these

42:08

patients is obviously the intramural segment of these.

42:12

That means if there is a segment that is inside the wall of the aorta, that's very

42:18

critical. And for that, we look at this slit-like

42:22

origin as well as lack of fat around it.

42:26

And not only that, coronary imaging also allows you to do endoluminal visualization

42:31

that sometimes can help and look at the lumen originating.

42:36

So this is in the same patient. This is the left coronary artery with very

42:40

round-looking lumen. There is the right coronary artery, has a slit-like lumen.

42:44

So you can give more perspective to the surgeon as well.

42:49

This is one excellent paper I always recommend people to read for anomalous

42:54

coronary arteries types and how we differentiate different types of coronary artery

43:00

origins. And this is one of my favorite figure out of this, because

43:05

inter-arterial course and subpulmonic or transseptal course gets confused very

43:10

frequently. And this differentiation is if you have anomalous coronary artery at

43:15

the level of the pulmonary valve, it is inter-arterial.

43:20

And if the same very similar course, but if it is at below the level of the

43:25

pulmonic valve and just going through the septum, then that's subpulmonic or

43:30

transseptal course.

43:33

This is just another example of how coronary imaging is useful and plays a

43:38

complementary role. This is a patient with chest pain, shortness of breath, and had

43:43

this echo. And on this echo, what was read is that this patient has very dilated

43:48

left coronary artery. And we suspected based on this echo and Doppler that there's

43:53

probably a fistula of why this is dilated.

43:57

But these are normal origin dilated coronaries, suspicion for fistula.

44:03

And we got this coronary exam thinking that we are going to find fistula.

44:07

And,

44:09

I'm sorry this is slightly fast. But focus on the origin of these coronaries.

44:14

And if you see this image, what you will see is that the

44:20

right coronary artery is originating from the aorta, but the left is

44:26

originating from the pulmonary artery.

44:29

So this is basically-- And you can understand why on echo it looked like it is

44:34

coming from the correct cusp because on this axial image at the level of the sinus

44:39

of Valsalva, that's how it looked. So what we were seeing was this image on echo.

44:45

What we did not see is this origin coming from here.

44:49

So that's why coronary CT is just so useful.

44:53

And not only that, this is another example in which this patient did not have

44:57

access to care, and the patient came in with a normal chest X-ray.

45:01

And this patient had

45:05

basically an infarct in the left circumflex distribution with a large

45:11

aneurysm, as well as presence of thrombus in that large aneurysm.

45:16

And just with cardiac CT, you can diagnose a lot of things.

45:19

And incidentally, on this patient, this patient also had an imperial

45:25

sinus venosus ASD. That means the IVC was not just going in the right atrium,

45:32

it was also connecting with the left atrium. So it was straddling together.

45:37

So Everything structural you can get from this test, and that's

45:43

why we see so much use. Now, very important area is also chest pain.

45:48

Like chest pain,

45:50

it's like preaching to the crowd. If you are here, I know you are interested in

45:54

this topic. So it's basically the second most common cause of ER visits, with

45:58

nearly eight million visits a year.

46:01

And what we have learned about data is that CCTA is,

46:07

if you define significant stenosis as more than 50%, CCTA is very

46:13

sensitive and the only thing where if you look at the data was

46:19

the specificity was low, especially when you look at the functionally significant

46:23

disease as compared to invasive FFR.

46:26

So this was the initial data which said, okay, CCTA has good sensitivity.

46:31

It has excellent negative predictive value.

46:33

That means when it is normal, the chances that this patient has anything wrong in

46:39

the coronary arteries is very, very low.

46:42

What it did not have was good specificity versus for functionally

46:47

significant or real IFR-positive disease.

46:53

But as we know, our

46:57

technology is improving. As we are going from a 16-slice scanner to now more than

47:02

128-slice scanners, our temporal resolution is reaching

47:08

around 60 millisecond now, and we are

47:13

requiring less contrast, we are giving less radiation, and we are having less

47:16

artifact. I already went through this.

47:19

Basically, this is showing how dual source scanners really are pushing the

47:23

boundaries of how fast you can image these patients.

47:27

And what we are learning is that more we see, so this is the data from CONFIRM

47:34

1 registry. Now, right now, we have CONFIRM 2 data that is coming out.

47:38

And what we are seeing is more disease versus outcome.

47:44

So survival probability when the CT is normal versus whenever there is a

47:48

three-vessel disease or left main disease is really, really bad.

47:51

But as you see, more disease, bad outcomes.

47:55

And not only that, this was shown in multiple pathway, in

48:01

multiple studies that even patients who have non-obstructive disease versus no

48:07

disease, the survival probability just with presence of any disease, even if it is

48:13

non-obstructive, is significantly decreased.

48:15

And we can see that one vessel versus two vessel versus three vessel disease, how

48:21

hazard ratio increases in these patients.

48:27

We know that, as we said, CCTA has very good negative predictive value.

48:32

So as we go and we have a negative scan, this really improves.

48:38

Basically, if you look at the ED studies, that if you have

48:44

a negative or a normal CCTA, the annual event rate with CT

48:50

is extremely, extremely low. Basically, it's 0.3%.

48:54

Versus if you compare it with SPECT, another test that is used for ischemia

48:59

evaluation, the event rate is higher.

49:02

And what we are learning with the SCOT-HEART registry, which I think really gives

49:08

insight into a lot of things because this was the initial SCOT-HEART paper that

49:13

talked about the five-year data that people who came in with chest pain and got CT,

49:20

just getting CT versus the standard of care, really the incident rate was

49:25

less. So same thing in PROMISE, we saw that patients

49:31

who got CT versus they were triaged with other modalities, the event

49:37

rate was much lower in the CT arm. So the question is: What is leading

49:42

to lower event rate and lower

49:47

rate of MACE in these patients, both for coronary death as well as

49:53

non-fatal myocardial infarction is basically what was shown was patients who got

49:59

CT, we were able to see even their non-obstructive disease as well as entire extent

50:04

of disease. So these patients were more on preventive therapies or when needed or

50:10

when indicated on aspirin, and that drives a lot of positive

50:15

outcomes in long-term. We obviously, when we report a CT, we follow

50:21

what is called as SCIRADS 2, in which we give a certain

50:27

basically grading of stenosis, which is basically no, minimal, mild, moderate,

50:31

severe. And

50:34

the advantage of using these standard techniques is that

50:41

this is where if you see, let's say you have a 50-year-old female that came

50:47

with atypical chest pain. Now, the question is, your CT here

50:52

is a normal coronary CTA. This patient has some non-obstructive disease

50:59

in three vessels. So all three vessels have disease, and this patient has

51:03

non-obstructive disease, but this plaque has highest features with positive

51:08

remodeling and low attenuation plaque.

51:10

But if you see, the nuclear scan or the SPECT exam in all

51:16

three scenarios would have been normal.

51:19

But obviously, the care of these patients does not have to be same.

51:24

This has to be different. And this is where CT really adds to it, and it has been

51:30

shown to be safe. It has been shown to be very efficient. It is fast.

51:36

You see ED turnaround times are much faster with use of CT.

51:42

And you can not only give stenosis, you can even give native plaque features out of

51:47

which we mainly talk of positive remodeling, low attenuation plaque,

51:53

neck-in-ring appearance, and spotty calcification.

51:56

These are the four highest features we frequently talk about in these, and these

52:01

are associated with basically also poor outcomes.

52:07

So for example, even if one feature is positive versus two feature positive, more

52:13

the bad features, the worse the outcome.

52:15

And there is so many studies that are coming out.

52:18

This is basically from SCOT-HEART trial that just total presence of low attenuation

52:23

plaque, which is a slightly counterintuitive in my head.

52:26

I always think of low attenuation plaque in a certain plaque as a risk of

52:32

rupture. But they just took total coronary volume, low

52:38

attenuation plaque, and if it was more than 4%, just look at how high the event

52:43

rate was versus people who had less than 4%.

52:46

So very useful data, and this is how plaque kind of

52:52

comes in the reports that you can quantify absolute amount of total plaque,

52:58

non-calcified plaque, calcified plaque.

53:01

And there is so much data coming out on this and how total plaque burden

53:07

and not just stenosis is the main predictor and risk of cardiovascular events and

53:12

death. Obviously, stenosis is a driver for patient symptoms, but plaque

53:17

burden is a very big driver of cardiovascular events as well as

53:23

death. So,

53:28

I would just briefly add to this that we also have CT is just seen as an anatomical

53:34

test, but we have an ability to add a functional test to this, and that

53:39

functional testing is what is called as a CTFFR.

53:43

And it's a generic term, I would say.

53:46

The reason I say CTFFR is a generic term is because it can be done with

53:52

computational flow dynamics, and there are multiple companies that have used

53:56

different approaches. One of the common one approach used is computational flow

54:01

dynamics, and this is basically an image based on this.

54:06

So what this image is showing is you are seeing stenosis.

54:10

Now, can you predict the functional significance of the stenosis?

54:15

And this is prediction.

54:18

Basically not absolute, so please do not take it as, oh, this shows less than

54:24

0.8,

54:25

and this has to be significant. So basically, CTFFR value is more than

54:31

or equal to 0.8 is normal. Less than 0.75 are abnormal, and

54:36

0.75 to 0.79 are kind of intermediate range.

54:41

But these are The CT-derived FFR. Now they are more than

54:48

computational flow dynamics models.

54:50

So please, there are AI-based models these days.

54:53

There are so many models that are now FDA approved, and that is not just the only

54:58

way to do computational flow dynamics.

55:01

But I just want to highlight how great that data is.

55:06

So basically, this is from one of the study that was done.

55:11

The end was not very high, but for stable chest pain, what they did was they used

55:17

how different modalities compare.

55:20

CTFFR with CCTA versus CCTA alone with no CTFFR

55:26

versus PET, versus SPECT. And the comparison is gold standard, that is invasive

55:31

FFR. And if you see these colors, what you will see is that fractional flow reserve

55:36

with CTFFR has had the best area under curve of 0.94,

55:42

followed by PET, followed by coronary CT alone, and then SPECT.

55:48

So this is basically how these things are being reflected.

55:52

And I want to add that this is data that recently came out

55:58

from 10 years from SCOT-HEART. I briefly showed you five-year SCOT-HEART.

56:03

And in long term, this data kind of continues to show the same.

56:09

If you go from five to 10, the benefit of triaging our patients through

56:15

CCTA continue to hold over time. And not only that,

56:21

you can see that these are non-fatal MI

56:26

in this group is basically lower, although the coronary revascularization

56:32

is similar. So it did not lead to multiple more coronary vascularization and yet

56:38

lead to less things. And the main thing it did it is that by having more

56:44

proportion of patients on preventive medication.

56:48

And if you see in all the years, this benefit kind of continues to go.

56:53

It was there at year five. It continues in year 10.

56:56

That's why this has become part of our guidelines as well as it has become part of

57:02

all of our

57:04

current chest pain guidelines and preventive guidelines.

57:07

With that, I would like to stop and answer these questions because I can go on for

57:13

another many, many minutes. So let me.

57:17

Thank you so much for this lecture. Yeah, there's a bunch of questions in the Q&A.

57:22

I say pick a couple since we're at time and yeah.

57:25

Okay.

57:27

What software do you use for plaque analysis?

57:32

So we have currently tried HeartFlow, and we tried it

57:38

as a part of our partnership at the SITE registry.

57:42

So that's the one that I have experience with.

57:45

But I've heard very good things about other softwares as well.

57:53

Have you begun looking at coronary artery periarterial fat attenuation

57:58

changes? I understand this may be a useful indicator of patients at risk for future

58:02

vascular events.

58:04

Absolutely. The data on PCAT, pericoronary adipose tissue or

58:12

FAI is increasing, and there's a lot of data that is suggesting that you can use it

58:18

as a marker of future events. I do have some concerns

58:24

about these techniques, is that, one, the study that showed that minus

58:30

70 is the magic number was only used in patients with stable chest pain.

58:36

And that, too, they characterize it along the right coronary artery.

58:40

Not sure if we can translate the same data to every coronary artery or every

58:44

patient scenario. I also think that the attenuation of these

58:49

fat is very dependent on protocol.

58:52

Like higher kV would change how the attenuation changes.

58:57

So I think there's a slight need to homogenize our protocols to make sure that

59:02

these are interoperable and consistent, so that the same patient goes to two

59:08

different sites, gets the same quantitative number.

59:11

But I do think as a

59:16

basic technique, I think it has a lot of value.

59:22

I was able to find my QA, so I can go from the top.

59:27

It says, right heart, we trigger off right pulmonary artery.

59:32

What is the attenuation that needs to be achieved?

59:34

So again, depends on what you are trying to achieve.

59:37

For our tricuspid imaging,

59:40

when we do right heart triggers, we usually rely on 150 Hounsfield units, and we

59:46

do give slightly diluted contrast, and that usually gives good imaging.

59:51

So I would say 150 is a good trigger to have for right heart evaluation.

59:58

Then it says, can you please re-explain how you scan protocol when you want

60:04

to concentrate contrast in the right ventricle, when you want to concentrate in

60:08

both ventricles? Okay. So whenever we are trying to do a right ventricle only

60:13

study, usually what I do is that I

60:17

use a biphasic kind of a protocol in which we take a prediluted contrast.

60:23

It's not a full

60:25

contrast, but it's a prediluted contrast.

60:28

We trigger off the main pulmonary artery at 150 Hounsfield unit, and there is a

60:33

saline chase that keeps coming after this. So that's how we do it.

60:37

Now for both ventricles, we don't use a prediluted contrast. We use that saline.

60:44

Sorry. We give concentrated contrast, then contrast saline mix, then saline.

60:50

And in that, we trigger off the aorta, descending thoracic aorta, and that is how

60:54

we achieve basic

60:57

enhancement. So the goal is the first bolus of the contrast that is coming in is

61:02

your bolus for the left heart. The contrast mix that is coming in, contrast saline

61:07

mix, that's your contrast for the right heart.

61:10

That's the goal of doing that kind of a study.

61:15

What are our options for dealing with motion after the scan has been performed?

61:19

That's a very good question. I think that I approach this two ways.

61:24

One, looking at different phases.

61:27

So obviously you want to be looking at different phases.

61:30

Now, also, a lot of scanners have motion correction algorithms.

61:37

I can tell you for single-source scanners, most because dual source do not have

61:42

these issues, so they have not really focused on this.

61:45

But at our site, I have GE scanners as well as Canon scanners, and both

61:51

have AI-based motion correction.

61:54

They really help in motion correction even at higher heart rates.

61:57

So I would suggest if you have a scanner, always turning on your motion correction.

62:03

In GE, it is called Snapshot Freeze.

62:07

I'm blanking on the name on Canon, but I think it is basically it's called some

62:13

form of a freeze or something, motion correction.

62:16

So just look at these options for your scanner.

62:23

Another one says, how do you change your protocol for grafts and stents?

62:27

Contrast volume sequential versus high-pitch helical reconstruction.

62:32

Great question. Grafts, you want to go higher, make sure that you always

62:37

include your Lima origin. Obviously, most commonly Lima is used.

62:43

So first is acquisition. Second is contrast volume.

62:47

We usually just increase it by 25 ML.

62:50

We do not change a lot in terms of contrast volume.

62:54

We still increase a little bit more because you are covering more territory.

62:58

You are covering more heart rates.

63:01

We

63:02

don't do high-pitch helical. High-pitch helical is only done for very young, ideal

63:08

heart rate, ideal patient. We rely very heavily in our

63:14

institution with sequential scanning.

63:17

I would say in bypass evaluation, either sequential or

63:22

retrospective helical with dose modulation are usually the right answers.

63:28

In terms of reconstructions, only thing I would change with only with stents, I

63:33

would not do anything different with grafts.

63:35

But with stent, you want basically a sharper kernel, which is either a lung or

63:41

a bone kernel. So just reconstruct one sharper kernel, which is bone or lung, and

63:48

with that reconstruction, you should be reading the exam.

63:51

So that's the one difference we do in stent patients.

63:56

How do you manage a patient with no

63:59

obstructive blood but high calcific blood burden?

64:04

I think this is a little bit of a question that

64:10

may not pertain much to cardiac CT, but managing the patient.

64:15

And I don't want to pretend to be the right person to answer this the

64:21

best way. But I do think whether if there is high calcific burden,

64:27

and there's no obstructive blood, the only binary difference I think is that, okay,

64:32

this patient does not go for CAT. But this patient goes through all the medical

64:37

management that this patient needs based on the risk factors as well as presence of

64:42

plaque burden. Now, obviously, there are guidelines based on, in the preventive

64:47

guidelines, they are based on what percentile the patient is on and

64:53

what is the absolute calcium score.

64:56

And based on that, it tells you how aggressive you need to be on

65:01

preventive therapy.

65:04

The guidelines on plaque quantification, absolute plaque quantification, not

65:08

calcium score quantification, but absolute plaque quantification are still a little

65:13

early. Although many registries and many clinical trials have tried to suggest,

65:19

oh, beyond this certain, you should add a PCSK9 inhibitor.

65:24

Beyond this, you add cholestyramine.

65:26

I don't know if they have penetrated

65:30

the clinical practice. But at the same time, as a radiologist, I really am not the

65:36

right person to fully answer this question.

65:41

Well, thank you so much for getting through all those questions and for your

65:44

lecture. Appreciate that.

65:46

Thank you. Thank you, Ashley. Thank you everyone for attending.

65:49

Yes. Thank you for everyone for participating and asking such great questions.

65:54

You can access the recording of today's noon conference and all our previous ones

65:58

by creating a free account. We'll also email out a link to the replay later today.

66:02

Be sure to join us next week on Tuesday, September 15th at 12:00 PM Eastern, where

66:06

Dr. Dorsaman will deliver a lecture entitled Introduction to Brain MRS.

66:11

You can register for that at medallia.com.

66:13

Follow us on social media for updates on future noon conferences.

66:16

Thanks again, and have a great day.

Report

Tags

Cardiac